A Trial to Evaluate the Efficacy of Poziotinib, Pan HER Inhibitor in Recurrent/Metastatic Esophageal Cancer (R/M ESCC)

Condition:   Inoperable or Recurrent or Metastatic Esophageal Squamous Carcinoma
Intervention:   Drug: Treatment with Poziotinib
Sponsor:   Yonsei University
Not yet recruiting

https://ift.tt/2EdtTJ6